By OmniThera Expression Profiler the activity of more than 20.000 human genes is analyzed
For personalized tumor therapy, the OmniThera Expression Profiler is a gene expression analysis that measures the activity of more than 20.000 human genes simultaneously (transcriptome) complemented by quantitative PCR and immunohistochemistry of genes playing key roles in important signaling pathways.
It offers a universally (not dependent on the type of tumor) applicable analytical platform for a multitude of clinically, highly relevant gene-activity-based analyses of tumor biology. The combination of universality and relatively low costs per gene provides oncologists with a wealth of valuable information not only for current therapeutic decisions but also possibly for innovative targeted therapies.
The treating physician (or the patient, respectively) receives a comprehensive molecular biological report with a critical evaluation and recommendation for treatment.
Applications
- Informs about the immune status of the tumor tissue including the responsiveness to checkpoint inhibitors, the sensitivity to various chemotherapeutic therapies as well as to natural compounds
- The assay is the cornerstone for the selection of individual cancer vaccine peptides on the transcriptome leve
Test sample requirements & Turnaround time
FFPE* / fresh tumor sample 
20 business days
* formalin-fixed, paraffin-embedded tissue
Logistics
In Germany, the lead time for transporting fresh tissue or pleural effusions and ascitic fluid is 48 hours before a planned procedure. For FFPE, we will contact the respective pathological institute to arrange the shipping.
